Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Minnesota medtech titan St. Jude Medical made a strong showing in San Francisco today, touting outcomes of its quadripolar pacing leads at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions.
For the 1st time, researchers found an 18.2% reduction in mortality for patients with quadripolar pacing when compared head-to-head with bipolar pacing, an important milestone for the technology. The results of the study were presented during a poster session at today’s conference. Read more
Boston Scientific’s lead-free S-ICD cardiac rhythm management made another strong showing, with results from an analysis of more than 880 patients showing relatively few complications.
In a poster session at today’s Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions, researchers unveiled nearly 2 years of data from the 2 largest S-ICD databases, saying that the device performed well relative to traditional implantable cardioverter defibrillators. Read more
As Medtronic’s resident technology scout and visionary, Dr. Stephen Oesterle’s job is to challenge the status quo at the world’s largest pure-play medical device company.
This morning Oesterle’s challenge to the medical device industry, issued at a meeting of the Massachusetts Medical Device Industry Council, was a sobering one. Read more